De novo variants in RHOBTB2, an atypical Rho GTPase gene, cause epileptic encephalopathy.
Hazrat BelalMitsuko NakashimaHiroshi MatsumotoKenji YokochiMariko Taniguchi-IkedaKazushi AotoMohammed Badrul AminAzusa MaruyamaHiroaki NagaseTakeshi MizuguchiSatoko MiyatakeNoriko MiyakeKazumoto IijimaShigeaki NonoyamaNaomichi MatsumotoHirotomo SaitsuPublished in: Human mutation (2018)
By whole exome sequencing, we identified three de novo RHOBTB2 variants in three patients with epileptic encephalopathies (EEs). Interestingly, all three patients showed acute encephalopathy (febrile status epilepticus), with magnetic resonance imaging revealing hemisphere swelling or reduced diffusion in various brain regions. RHOBTB2 encodes Rho-related BTB domain-containing protein 2, an atypical Rho GTPase that is a substrate-specific adaptor or itself is a substrate for the Cullin-3 (CUL3)-based ubiquitin ligase complex. Transient expression experiments in Neuro-2a cells revealed that mutant RHOBTB2 was more abundant than wild-type RHOBTB2. Coexpression of CUL3 with RHOBTB2 decreased the level of wild-type RHOBTB2 but not the level of any of the three mutants, indicating impaired CUL3 complex-dependent degradation of the three mutants. These data indicate that RHOBTB2 variants are a rare genetic cause of EEs, in which acute encephalopathy might be a characteristic feature, and that precise regulation of RHOBTB2 levels is essential for normal brain function.
Keyphrases
- wild type
- copy number
- magnetic resonance imaging
- liver failure
- early onset
- white matter
- poor prognosis
- newly diagnosed
- induced apoptosis
- respiratory failure
- resting state
- computed tomography
- drug induced
- ejection fraction
- binding protein
- magnetic resonance
- dna methylation
- prognostic factors
- functional connectivity
- oxidative stress
- blood brain barrier
- transcription factor
- multiple sclerosis
- amino acid
- neural network
- patient reported
- extracorporeal membrane oxygenation